Andrew Paris
About Andrew Paris
Andrew Paris is the Director of Early Clinical Development at Bristol Myers Squibb and an Adjunct Assistant Professor at the University of Pennsylvania Perelman School of Medicine. He has a diverse background in medicine, research, and education, with numerous contributions to early clinical development and biotechnology.
Current Positions at Bristol Myers Squibb and University of Pennsylvania
Andrew Paris serves as the Director of Early Clinical Development at Bristol Myers Squibb, where he oversees various projects and initiatives related to early-phase clinical trials. Concurrently, he holds the role of Adjunct Assistant Professor at the University of Pennsylvania Perelman School of Medicine. In this academic capacity, he contributes to the education and mentorship of medical students and residents.
Previous Roles and Experience
Andrew Paris has a substantial professional history, including four years as an Instructor of Medicine at the University of Pennsylvania School of Medicine. He also served as a Postdoctoral Fellow there for 11 months. Paris gained valuable experience as a Fellow in Pulmonary & Critical Care Medicine at Penn Medicine, University of Pennsylvania Health System for three years. Further, he completed a three-year tenure as an Intern and Resident in Internal Medicine at Yale New Haven Hospital.
Educational Background and Academic Achievements
Andrew Paris's academic journey includes a BA in History from the University of Pennsylvania, an MD from the Icahn School of Medicine at Mount Sinai, and an ALM in Biotechnology from Harvard University. His educational background has equipped him with a comprehensive understanding of both historical and scientific perspectives, which he uses in his professional endeavors.
Research and Publications
Andrew Paris has authored multiple research papers in peer-reviewed journals, focusing on early clinical development and biotechnology. His scholarly work has been recognized and presented at various international conferences, including the American Society of Clinical Oncology (ASCO) Annual Meeting. He also actively engages in early-phase clinical trials as a principal investigator.
Certifications and Awards
Andrew Paris holds a certification in Pulmonary Disease and Critical Care Medicine from the American Board of Internal Medicine. He was awarded the Young Investigator Award by the American Thoracic Society in 2018 and has participated in the development of new clinical protocols that have been widely adopted across multiple healthcare institutions.